Strategic Family Wealth Counselors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AVXL
VCM
SF
VPM
Strategic Family Wealth Counselors's AVXL Position: Q1 2026 in Review
Strategic Family Wealth Counselors opened a new position in Anavex Life Sciences (AVXL) in Q1 2026: 8,045 shares worth $24.7K. The stake represents 0.01% of the portfolio and ranks #161 among its holdings. This is a return to the name: Strategic Family Wealth Counselors previously reported a position in AVXL as recently as Q3 2025.
Strategic Family Wealth Counselors first reported a position in AVXL in Q1 2025 and has held it in 4 quarters since. The position peaked at $69.6K in Q2 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.
- Strategic Family Wealth Counselors held 8,045 shares of Anavex Life Sciences worth $24.7K as of Q1 2026.
- Anavex Life Sciences was a new Strategic Family Wealth Counselors position in Q1 2026.
- Anavex Life Sciences made up 0.01% of Strategic Family Wealth Counselors's portfolio in Q1 2026, its #161 holding.
- Strategic Family Wealth Counselors first reported a position in Anavex Life Sciences in Q1 2025 and has held it in 4 quarters since.
- Strategic Family Wealth Counselors's Anavex Life Sciences position peaked at $69.6K in Q2 2025.
- 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.
Based on Strategic Family Wealth Counselors's 13F filing for Q1 2026, filed 11 May 2026.